UBS inks €77m forward-funding deal for UK life sciences asset

UBS Asset Management (UBS-AM) Real Estate & Private Markets (REPM) has agreed to provide £66 mln (€77 mln) in forward funding for a pharmaceutical facility in Stevenage, UK, working with development partner Reef Estates.

Would you like to read more? Log in first (top right of the screen) or take a trial.